4 | Neutralizing AntibodiesIBA
01/2022
-
07/2012 |
3 | AntibodiesIBA
01/2022
-
01/2017 |
3 | Antiviral Agents (Antivirals)IBA
11/2020
-
01/2012 |
3 | Glycoproteins (Glycoprotein)IBA
01/2019
-
09/2015 |
3 | CytokinesIBA
01/2019
-
08/2010 |
3 | Purinergic Receptors (Receptors, Purine)IBA
01/2019
-
10/2014 |
3 | Proteins (Proteins, Gene)FDA Link
01/2017
-
12/2013 |
2 | EpitopesIBA
01/2022
-
07/2012 |
2 | 3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA
01/2020
-
01/2019 |
2 | 4,4,',4'',4'''- (carbonylbis(imino- 5,1,3- benzenetriylbis(carbonylimino)))tetrakis(benzene- 1,3- disulfonate)IBA
01/2020
-
01/2019 |
2 | Purinergic P2X1 ReceptorsIBA
01/2020
-
01/2019 |
2 | Broadly Neutralizing AntibodiesIBA
01/2020
-
01/2017 |
2 | Purinergic AntagonistsIBA
01/2018
-
10/2014 |
1 | Biotin (Vitamin H)FDA Link
01/2021 |
1 | Oxygen (Dioxygen)IBA
11/2020 |
1 | VaccinesIBA
11/2020 |
1 | NF 279IBA
01/2020 |
1 | Interleukin-10 (Interleukin 10)IBA
01/2019 |
1 | Zidovudine (Retrovir)FDA LinkGeneric
01/2019 |
1 | Purinergic P2X7 ReceptorsIBA
01/2019 |
1 | Interleukin-1beta (Interleukin 1 beta)IBA
01/2019 |
1 | Tyrosine (L-Tyrosine)FDA Link
01/2017 |
1 | NigericinIBA
03/2016 |
1 | Biological ProductsIBA
03/2016 |
1 | Simvastatin (Zocor)FDA LinkGeneric
03/2016 |
1 | HIV Fusion InhibitorsIBA
03/2016 |
1 | Interleukin-8 (Interleukin 8)IBA
01/2016 |
1 | Interleukin-6 (Interleukin 6)IBA
01/2016 |
1 | ChemokinesIBA
01/2016 |
1 | Amino AcidsFDA Link
09/2015 |
1 | Biomarkers (Surrogate Marker)IBA
01/2015 |
1 | Anti-HIV Agents (AIDS Drugs)IBA
10/2014 |
1 | AntigensIBA
01/2013 |
1 | Monoclonal AntibodiesIBA
07/2012 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2012 |
1 | Green Fluorescent ProteinsIBA
01/2011 |
1 | Viral ProteinsIBA
01/2011 |
1 | RNA (Ribonucleic Acid)IBA
08/2010 |
1 | Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2010 |
1 | CollagenIBA
08/2010 |
1 | Complement System Proteins (Complement)IBA
05/2006 |